Pharma Firms Boost Lobbying in Race for Virus Treatment, Vaccine

(Bloomberg) -- Several drugmakers bolstered their federal lobbying in the second quarter of the year as the coronavirus pandemic created an urgent and potentially lucrative race for medicines, vacc...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.